Assessing Genpact (G) Valuation After Recent Choppy Share Price Performance

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.

Genpact (G) has drawn investor attention after its recent trading performance, with the share price closing at $38.30 as some returns over the past year and past 3 months turned negative.

For readers tracking the stock, recent moves sit against a backdrop of US$5,079.88m in annual revenue, net income of US$552.49m, and a market value of about US$6.50b based on current data.

See our latest analysis for Genpact.

Recent trading has been choppy, with a 7 day share price return of 6.27% and a 90 day share price return of 19.82%, while the 1 year total shareholder return of 23.08% points to fading momentum over a longer horizon.

If this kind of mixed performance has you looking for other ideas, it could be a good time to broaden your watchlist with 20 top founder-led companies.

With Genpact trading around $38.30, a US$6.50b market value and analyst targets implying some upside, the key question is whether the current valuation still leaves room for opportunity or if the market is already pricing in future growth.

Genpact's most followed narrative pegs fair value at $48.64 per share, comfortably above the last close of $38.30. This puts the focus firmly on future cash generation and earnings quality.

Genpact's strong pipeline, particularly in high-growth verticals like high tech, manufacturing, and financial services, combined with increasing large-deal activity and stable operating leverage, sets the stage for above-sector-average revenue and EPS growth, aided by operating margin expansion and continued return of capital to shareholders.

Read the complete narrative.

Curious what underpins that $48.64 figure? The narrative leans on steady revenue gains, firmer margins, and a future earnings multiple that stays below many peers. The exact mix might surprise you.

The fair value estimate uses a 7.80% discount rate to bring projected earnings and cash flows back to today, which helps explain why the narrative points to upside despite recent share price weakness. Analysts behind this view are also assuming moderate top line growth and profit margins broadly in line with Genpact's recent performance, rather than aggressive blue sky numbers.

Result: Fair Value of $48.64 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, slower momentum in core outsourcing services and a muted demand backdrop in areas like Consumer Healthcare could easily knock this upbeat valuation story off course.

Find out about the key risks to this Genpact narrative.

The mix of optimism and caution around Genpact is clear, so it makes sense to move quickly and test the thesis against hard numbers yourself. A good place to start is with the 5 key rewards.

If Genpact has caught your eye, do not stop here. Broaden your search now and let carefully filtered stock lists surface ideas you might otherwise miss.

Target potential upside by scanning companies that screen as 49 high quality undervalued stocks and see which ones deserve a place on your radar.

Prioritize resilience by focusing on businesses highlighted in the 73 resilient stocks with low risk scores so you can concentrate on steadier profiles.

Hunt for future leaders hiding in plain sight with the screener containing 26 high quality undiscovered gems and spot names before they are widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include G.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com